 | Articles: General Pharma
|
Momenta Pharmaceuticals Announces Filing of Abbreviated New Drug Application With a Paragraph IV Certification for Generic Version of Copaxone
Corporate News Releases, 07/15/08
Perrigo Company Announces Appointment of New Board Member
Corporate News Releases, 07/15/08
TREDAPTIVE(TM) (nicotinic acid /laropiprant) Approved in the European Union: New Lipid-Modifying Therapy to Treat LDL-C, HDL-C and Triglycerides
Corporate News Releases, 07/15/08
 | | Sponsor |
Teva Comments on Paragraph IV Filing for COPAXONE(R); Intends to File Lawsuit against Generic Filer for Patent Infringement
Corporate News Releases, 07/15/08
VNUS Medical Technologies, Inc. Announces Board of Director Resignation
Corporate News Releases, 07/15/08
Bionanotechnology and the Foundations of Nanomedicine
PharmiWeb, 07/15/08
Lilly to acquire SGX Pharmaceuticals for $64 million
PharmiWeb, 07/15/08
Role of Gabapentin in the Treatment of Uremic Pruritus
Annals of Pharmacotherapy, 07/15/08
Lilly Partners With the National Council of La Raza to Fight Chronic Disease
Lilly, 07/15/08
Teva Comments on Paragraph IV Filing for COPAXONE Intends to File Lawsuit against Generic Filer for Patent Infringement
Teva Pharmaceutical Industries, 07/15/08
|
 Receive daily email updates on General Pharma
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
 |
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
 |
| Sponsor |
|
